Diagnosis and treatment of pulmonary alveolar microlithiasis.
Emiralioglu N, Beken B, Ozcan HN, Yalcin E, Dogru D, Ozcelik U, Haliloglu M, Kiper N.
Emiralioglu N, et al.
Pediatr Int. 2016 Aug;58(8):805-7. doi: 10.1111/ped.13032.
Pediatr Int. 2016.
PMID: 27553891
Pulmonary alveolar microlithiasis (PAM) is a rare genetic disease caused by mutations in sodium-phosphate co-transporter (SLC34A2), which encodes a type 2b sodium phosphate co-transporter. ...Turkey has a high prevalence of PAM. Herein, we report the clini …
Pulmonary alveolar microlithiasis (PAM) is a rare genetic disease caused by mutations in sodium-phosphate co-transporte …